Activation of p38/JNK pathway is responsible for embelin induced apoptosis in lung cancer cells: Transitional role of reactive oxygen species

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Avisetti, Deepa R ^a,b   Babu, K Suresh ^b   Kalivendi, Shasi V ^a,b  

^a ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

^b INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; EMBELIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; X LINKED INHIBITOR OF APOPTOSIS;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CYTOTOXICITY ASSAY; DRUG EFFICACY; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; LUNG CANCER; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANNEXIN A5; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOQUINONES; BLOTTING, WESTERN; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; FLUORESCEIN-5-ISOTHIOCYANATE; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MICROARRAY ANALYSIS; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; RHODAMINES;

EID: 84899567691     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087050     Document Type: Article

References (34)

1. Chitra M, Sukumar E, Suja V, Devi CS (1994) Antitumor, anti-inflammatory and analgesic property of embelin, a plant product. Chemotherapy 40 (2): 109-113.
2. Gandhi GR, Stalin A, Balakrishna K, Ignacimuthu S, Paulraj MG, et al. (2013) Insulin sensitization via partial agonism of PPARγ and glucose uptake through translocation and activation of GLUT4 in PI3K/p-AKT signalling pathway by embelin in type 2 diabetic rats. Biochim Biophys Acta. 1830 (1): 2243-2255.
3. Chaudhari HS, Bhandari U, Khanna G (2012) Preventive effects of embelin from Embelia ribes on lipid metabolism and oxidative stress in high-fat dietinduced obesity in rats. Planta Med. 78(7): 651-657.
4. Johri RK, Pahwa GS, Sharma SC, Zutshi U (1991) Determination of estrogenic/antiestrogenic potential of antifertility substances using rat uterine peroxidise assay. Contraception 44 (5): 549-557.
5. Githiori JB, Höglund J, Waller PJ, Leyden Baker R (2003) Evaluation of anthelmintic properties of extracts from some plants used as livestock dewormers by pastoralist and smallholder farmers in Kenya against Heligmosomoides polygyrus infections in mice. Vet Parasitol. 118(3-4): 215-226. (Pubitemid 38068283)
6. Nikolovska-Coleska Z, Xu L, Hu Z, Tomita Y, Li P, et al. (2004) Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem. 2004 47(10): 2430-2440. (Pubitemid 38580082)
7. Lu J, Huang Y, Zhao W, Marquez RT, Meng X, et al. (2013) PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers. Biomaterials 34(5): 1591-1600.
8. Park SY, Lim SL, Jang HJ, Lee JH, Um JY, et al. (2013) Embelin induces apoptosis in human glioma cells through inactivating NF-κB. J Pharmacol Sci. 121(3): 192-199.
9. Heo JY, Kim HJ, Kim SM, Park KR, Park SY, et al. (2011) Embelin suppresses STAT3 signalling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN. Cancer Lett. 308(1): 71-80.
10. Schaible AM, Traber H, Temml V, Noha SM, Filosa R, et al. (2013) Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin. Biochem Pharmacol. 86 (4): 476-486.
11. Modak R, Basha J, Bharathy N, Maity K, Mizar P, et al. (2013) Probing p300/CBP Associated Factor (PCAF)-Dependent Pathways with a Small Molecule Inhibitor. ACS Chem Biol. May 9. doi: 10.1021/cb4000597 [Epub ahead of print].
12. Lin Z, Jensen JK, Hong Z, Shi X, Hu L, et al. (2013) Structural insight into inactivation of plasminogen activator inhibitor-1 by a small-molecule antagonist. Chem Biol. 20 (2): 253-261.
13. Joshi R, Ghanty TR, Mukherjee T (2009) Formation of semiquinone radical in the reaction of embelin (2,5-dihydroxy-3-undecyl-1,4-benzoquinone) with reductants as well as oxidants. Characterization by pulse radiolysis and structure investigation by quantum chemical study. J Mol Struct. 928: 46-53.
14. Makawiti DW, Konji VN, Olowookere JO (1990) Interaction of benzoquinones with mitochondria interferes with oxidative phosphorylation characteristics. FEBS Lett. 266(1-2): 26-28. (Pubitemid 20194164)
15. Joy B, Sivadasan R, Abraham TE, John M, Sobhan PK, et al. (2010) Lysosomal destabilization and cathepsin B contributes for cytochrome c release and caspase activation in embelin-induced apoptosis. Mol Carcinog. 49(4): 324-336.
16. Hussain AR, Uddin S, Ahmed M, Bu R, Ahmed SO, et al. (2010) Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling. J Pathol. 222(2): 180-190.
17. Dai Y, Qiao L, Chan KW, Yang M, Ye J, et al. (2009) Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Cancer Res. 69(11): 4776-4783.
18. Chitra M, Devi CS, Viswanathan S, Sukumar E (2003) Antibacterial activity of embelin. Fitoterapia 74: 401-403. (Pubitemid 36623308)
19. Chitra M, Devi CS, Viswanathan S, Sukumar E (2003) Effect of embelin on lipid profile in transplanted fibrosarcoma in rats. Indian J. Pharmcol. 35: 241-244. (Pubitemid 36998728)
20. Vichai V, Kirtikira K (2006) Sulphorhodamine B colorimetric assay for cytotoxicity screening. Nat. Protoc. 1(3): 1112-1116.
21. Gurtu V, Kain SR, Zhang G (1997) Fluorometric and colorimetric detection of caspase activity associated with apoptosis. Anal Biochem. 251(1): 98-102. (Pubitemid 27352149)
22. Dhanasekaran A, Kotamraju S, Kalivendi SV, Matsunaga T, Shang T, et al. (2004) Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis. J Biol Chem. 279(36): 37575-37587. (Pubitemid 39195471)
23. Kalivendi SV, Konorev EA, Cunningham S, Vanamala SK, Kaji EH, et al. (2005) Doxorubicin activates nuclear factor of activated T lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochem J. 389 (Pt 2): 527-539. (Pubitemid 41021156)
24. Fandy TE, Shankar S, Srivastava RK (2008) Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells. Mol. Cancer 7: 60.
25. Konorev EA, Vanamala S, Kalyanaraman B (2008) Differences in doxorubicin-induced apoptotic signalling in adult and immature cardiomyocytes. Free Radic Biol Med. 45 (12): 1723-1728.
26. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, et al. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N- terminal kinase. Proc Natl Acad Sci U S A. 98(24): 13681-13686. (Pubitemid 33115958)
27. Kayali AG, Austin DA, Webster NJ (2000) Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes. Diabetes 49(11): 1783-1793.
28. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P (2008) Redox regulation of cell survival. Antioxid Redox Signal. 10(8): 1343-1374.
29. Allensworth JL, Aird KM, Aldrich AJ, Batinic-Haberle I, Devi GR (2012) XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells. Mol Cancer Ther. 11(7): 1518-1527.
30. Ahn KS, Sethi G, Aggarwal BB (2007) Embelin, an inhibitor of X chromosomelinked inhibitor-of-apoptosis protein, blocks nuclear factor-κB (NF-κB) signaling pathway leading to suppression of NF-κB-regulated antiapoptotic and metastatic gene products. Mol Pharmacol. 71(1): 209-219. (Pubitemid 46020991)
31. Kim SW, Kim SM, Bae H, Nam D, Lee JH, et al. (2013) Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades. Prostate 73(3): 296-305.
32. Wada T, Penninger JM (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23: 2838-2849. (Pubitemid 38638846)
33. Balmanno K, Cook SJ (2009) Tumour cell survival signalling by the ERK 1/2 pathway. Cell Death Differ. 2009; 16(3): 368-77.
34. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270(5240): 1326-1331.